Gene expression profiles of poor-prognosis primary breast cancer correlate with survival

Human Molecular Genetics

Volumn 11, Issue 8, 2002, Pages 863-872

  Bertucci, François ^a,b,c   Nasser, Valéry ^a   Granjeaud, Samuel ^a   Eisinger, François ^b   Adelaïde, José ^a   Tagett, Rebecca ^b   Loriod, Béatrice ^a   Giaconia, Aurélia ^a   Benziane, Athmane ^b   Devilard, Elisabeth ^b   Jacquemier, Jocelyne ^b   Viens, Patrice ^b,c   Nguyen, Catherine ^a   Birnbaum, Daniel ^a,c,d   Houlgatte, Rémi ^a  

^a Aix Marseille university   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DNA MICROARRAY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC CODE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; METASTASIS; OUTCOMES RESEARCH; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING;

EID: 18344378043     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.8.863     Document Type: Article

References (46)

1. Polychemotherapy for early breast cancer: An overview of the randomised trials
2. Tamoxifen for early breast cancer: An overview of the randomised trials
3. Update on adjuvant chemotherapy for early breast cancer
4. The Chipping Forecast
5. Expression profiling: DNA arrays in many guises
6. Genomic analysis of metastasis reveals an essential role for RhoC
7. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells
8. A gene expression database for the molecular pharmacology of cancer
9. Chemosensitivity prediction by transcriptional profiling
10. Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance
11. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
12. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
13. Molecular portraits of human breast tumours
14. Gene expression profiling of primary breast carcinomas using arrays of candidate genes
15. Linking gene expression patterns to therapeutic groups in breast cancer
16. Gene-expression profiles in hereditary breast cancer
17. Molecular classification of cutaneous malignant melanoma by gene expression profiling
18. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
19. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
20. Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification
21. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles
22. Diversity of gene expression in adenocarcinoma of the lung
23. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
24. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
25. Correlation of primary breast cancer histopathology and estrogen receptor content
26. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer
27. Prognostic significance of MUC1 epithelial mucin expression in breast cancer
28. Strong association between c-myb and oestrogen-receptor expression in human breast cancer
29. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables
30. Regulation and localization of cellular retinol-binding protein, retinol-binding protein, cellular retinoic acid-binding protein (CRABP) and CRABP II in the uterus of the pseudopregnant rat
31. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
32. Two human homologues of Saccharomyces cerevisiae SW12/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor
33. GATA-3 is expressed in association with estrogen receptor in breast cancer
34. Angiogenin expression and prognosis in primary breast carcinoma
35. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
36. Multidrug resistance in breast cancer: A meta-analysis of MDR1/gp170 expression and its possible functional significance
37. Prognostic significance of cathepsins B and L in primary human breast cancer
38. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers
39. Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression
40. Prolactin as a chemoattractant for human breast carcinoma
41. Expression of prolactin and its receptor in human breast carcinoma
42. Expression scanning of an array of growth control genes in human tumor cell lines
43. FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers
44. Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples
45. Cluster analysis and display of genome-wide expression patterns
46. Nonparametric estimation from incomplete observations